$heff's $tation of $tocks & $olid DD

[ash111]

MRNS 2.83 +17%, that's why you do DD's...CBLI a strong commitment.
: Yakov Kogan, Ph.D., MBA, Chief Executive Officer, stated, “The pursuit of approval by the EMA and FDA and commercialization for entolimod as a medical radiation countermeasure remains our 
top priority.”
http://www.otcmarkets.com/edgar/GetFilingPdf?FilingID=12230538

"At June 30, 2017 , we had cash, cash equivalents and short-term investments of $11.5 million in the aggregate. Management believes this capital will fund the Company's operations and cash requirements for at least 12 months beyond the filing date of this Quarterly Report on Form 10-Q".

CBLI https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133642497&txt2find=cbli

LINK BACK TO MRNS DD.